Wasting No Time: General Practitioners Clamor for Complimentary Meds for Long-Covid Sufferers
Medical professionals advocate for supplying prescription drugs at no cost to individuals dealing with Long COVID. - Medical professionals advocate for supply of free medication for extended COVID-19 patients at home.
Here's the deal: Long-Covid patients are left footing the bill for off-label meds, according to Markus Beier, head honcho of the General Practitioners' Association. He aptly said in the Rheinische Post, "Enough is enough! Time to change this ASAP." But, don't fret; there's no approved meds for Long Covid yet.
Now, hair off the capital B, Federal Research Minister Dorothee Bär (CSU) dropped a bomb by announcing the escalation of Long-Covid research in collaboration with Health Minister Nina Warken (CDU). Ever-thoughtful, Beier added, "This is a step in the right direction, but more investment in research is essential."
Oh, and on the topic of lingering virus effects, Long Covid is yet another unwelcome development stemming from COVID-19 infections. The Association is ardently advocating for better medication and research for the same, just like many countries worldwide are, grappling with similar challenges.
- Long Covid
- Medication
- General Practitioners' Association
- General Practitioners
- Markus Beier
- Rheinische Post
- Dorothee Bär
- Nina Warken
- Long-term health effects of Covid-19
- Markus Beier, from the General Practitioners' Association, urges a swift change in the current policy, as Long-Covid patients are currently footing the bill for off-label medications.
- The General Practitioners' Association, along with many other countries, is advocating for better medication and research on Long Covid, given its long-term health effects.
- In an effort to address the long-term health effects of Covid-19, Federal Research Minister Dorothee Bär and Health Minister Nina Warken have announced a collaboration to escalate Long-Covid research.
